Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
about
MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapyAdvanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesFeasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative ReviewSupratracheal laryngectomy: current indications and contraindications.Concurrent chemoradiation for high-risk prostate cancerWhat is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.An update on larynx cancerFollow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our ExperienceTailoring Adjuvant Radiation Therapy by Intraoperative Imaging to Detect Residual Cancer.Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.The role of neck dissection in squamous cell carcinoma of the head and neck.Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.Transoral laser surgery for laryngeal cancer.Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerAssessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges.Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancerCisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatmentChemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancerDefinitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.Transoral laser microsurgery for laryngeal carcinoma: Survival analysis in a hospital-based population.Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective.HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.Treatment of T3 laryngeal cancer in the Netherlands: a national survey.MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.Pretreatment computed tomographic gross tumor volume as predictor of persistence of tracheostomy and percutaneous endoscopic gastrostomy tube in patients undergoing larynx preservation.Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer.Telephonic voice intelligibility after laryngeal cancer treatment: is therapeutic approach significant?Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control studyFinal results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
P2860
Q26747068-161988AD-0D2D-4166-8D00-81B919680EF9Q26767046-F901F63D-42A0-4DA9-84B2-D6E606BFA2A2Q26783599-493C3F2D-BA65-4F18-AD7D-F5E10C87128BQ26798282-18E66BFC-8CB3-4D55-AB6A-4A0057E56372Q26798912-E959ACDE-9D84-4D04-A199-4B83AEDBFE83Q27026269-D7681B28-046E-4403-B691-5FA4F899AA83Q27853245-D1F2FED9-4ACE-491D-814C-C38C4C050878Q28079132-9AACEECD-1936-46FB-8763-27D00452C96FQ28080298-F13CEC97-7C31-4DDC-9816-6EDEC4303E40Q28084315-031ABD96-04CD-4A71-9538-3F3D0EB91FF8Q30361804-5A285D74-5B70-4711-A0BD-6DA103D2DE91Q30366869-BC0EE71E-F339-42A5-B1F9-1F4F5CF9647FQ31063952-B1F36D00-CA92-41E8-AA4D-B98BC28F472BQ31136094-BD258A59-2380-4931-9A1F-F92680331319Q31160694-5FA96C53-51C0-43F9-B6EA-473B8CA21E99Q33571937-686CB2C6-D1D1-4911-BC72-129D9EF8B868Q33711438-5A24A552-107F-4FA3-9C73-E73357607F23Q33753722-2FA22392-F9DC-4913-9EC2-BFF1C102374FQ33891615-71922DA3-BD44-496A-B829-B86E93AC6D25Q33943031-6472EE29-8924-4507-9262-73728A7383D9Q34691622-94D9A2C5-2200-445C-A0A2-E97EF9192EF4Q35019239-0AB99357-99D4-4E13-A759-2A8F0D945D5DQ35163304-B96372C4-9F60-4FD8-BD87-5CADF9363F54Q35175575-078C6E5A-7EC0-430B-98EA-3F23B5CC99B4Q35534813-FA2A9195-76A2-42B1-B731-A6B788D9CA2AQ35592731-6CD9D865-A3A9-4F9F-80BA-0807172EE903Q35762184-359F0A7B-ED21-4418-BCF3-687D4E92A309Q35782292-8515C58B-3109-479A-A36E-5C92B68C23CCQ35828640-F7C0153C-0C91-4A7C-8D97-B071C7746A42Q35922705-405F2C98-6011-4479-87D2-AB03F3365B6EQ36004137-A10AED2E-D6EE-4609-8F28-A3537D1DE526Q36049570-E4550F36-8500-45EB-A3F8-F6801A004B74Q36066977-0DE7361D-175B-404F-973A-C7BB50ED0E05Q36082263-B1007C07-024E-49C9-ABDE-C500768AE9F4Q36191405-EAC63101-CF6E-49BC-A3BB-5A759C4A3553Q36251788-68F6C0B2-34CC-4426-8774-7984A71087CCQ36332315-1D55CB3C-DB03-4DF0-AFD5-09DC31C95BE0Q36378279-99B43A05-BABC-479F-AABA-AFA0E88E57D6Q36452263-E5626ED8-A00F-4C65-8106-F24E2F4C2CD7Q36482404-30A1B416-CB8D-4ED0-B358-49839AFD6A94
P2860
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Long-term results of RTOG 91-1 ...... ocally advanced larynx cancer.
@ast
Long-term results of RTOG 91-1 ...... ocally advanced larynx cancer.
@en
type
label
Long-term results of RTOG 91-1 ...... ocally advanced larynx cancer.
@ast
Long-term results of RTOG 91-1 ...... ocally advanced larynx cancer.
@en
prefLabel
Long-term results of RTOG 91-1 ...... ocally advanced larynx cancer.
@ast
Long-term results of RTOG 91-1 ...... ocally advanced larynx cancer.
@en
P2093
P2860
P356
P1476
Long-term results of RTOG 91-1 ...... ocally advanced larynx cancer.
@en
P2093
Andy Trotti
Arlene A Forastiere
Bonnie Glisson
Helmuth Goepfert
Henry Wagner
Jay S Cooper
John A Ridge
John F Ensley
Moshe H Maor
Qiang Zhang
P2860
P304
P356
10.1200/JCO.2012.43.6097
P407
P577
2012-11-26T00:00:00Z